Magainin Pharmaceuticals Inc. said Tuesday that it has filed aregistration statement with the Securities and ExchangeCommission for a proposed public offering of 3.5 million sharesof common stock.
The offering is being managed by Hambrecht & Quist Inc.,Smith Barney, Harris Upham & Co. and S.G. Warburg SecuritiesInc.
Stock in the Plymouth Meeting, Pa., company (NASDAQ:MAGN)was unchanged on Tuesday at $6.
(c) 1997 American Health Consultants. All rights reserved.